Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,695,685
-$35,702 QoQ
Shares Held
461,384
-0.7% QoQ
Ownership
0.464%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 209 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. SPRY ranks #77 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in SPRY

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,695,685 461,384
2026-03-31 $3,731,387 464,681
2025-12-31 $3,546,783 304,445
2025-09-30 $3,368,237 335,148
2025-06-30 $5,682,504 325,645
2025-03-31 $3,520,386 279,840
2024-12-31 $2,609,162 247,314
2024-09-30 $3,400,786 234,537
2024-06-30 $230,459 27,081
2024-03-31 $132,246 12,940
2023-12-31 $70,911 12,940
2023-09-30 $48,913 12,940
2020-12-31 $2,668,025 57,575